Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Patterson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 LigaseKlemens Hoegenauer, Shaojian An, Jake Axford, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 LigaseKlemens Hoegenauer, Shaojian An, Jake Axford, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Pageof 2